Search Results - "Drobacheff‐Thiebaud, M‐C"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Is long‐term virological response related to CCR5 Δ32 deletion in HIV‐1‐infected patients started on highly active antiretroviral therapy? by Laurichesse, J‐J, Taieb, A, Capoulade‐Metay, C, Katlama, C, Villes, V, DrobacheffThiebaud, MC, Raffi, F, Chêne, G, Theodorou, I, Leport, C

    Published in HIV medicine (01-04-2010)
    “…Objective The aim of the study was to determine whether the chemokine (C‐C motif) receptor 5 (CCR5) Δ32 deletion is associated with long‐term response to…”
    Get full text
    Journal Article
  2. 2

    Is long-term virological response related to CCR5 32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy? by Laurichesse, J-J, Taieb, A, Capoulade-Metay, C, Katlama, C, Villes, V, Drobacheff-Thiebaud, M-C, Raffi, F, Chene, G, Theodorou, I, Leport, C

    Published in HIV medicine (01-04-2010)
    “…ObjectiveThe aim of the study was to determine whether the chemokine (C-C motif) receptor 5 (CCR5) 32 deletion is associated with long-term response to…”
    Get full text
    Journal Article
  3. 3

    Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy? by Laurichesse, J-J, Taieb, A, Capoulade-Metay, C, Katlama, C, Villes, V, Drobacheff-Thiebaud, M-C, Raffi, F, Chêne, G, Theodorou, I, Leport, C

    Published in HIV medicine (01-04-2010)
    “…The aim of the study was to determine whether the chemokine (C-C motif) receptor 5 (CCR5) Delta32 deletion is associated with long-term response to combination…”
    Get full text
    Journal Article